Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Advanced Visualization | March 09, 2016

The Unsettling Evolution of Advanced Visualization

The Unsettling Evolution of Advanced Visualization

Browser-based enterprise viewing promises to bridge the gap between EMR and PACS. (Image courtesy of TeraRecon)

“You keep same-in’ when you ought to be a changin’ … One of these days these boots are gonna walk all over you.”

— “These boots are made for walking,” Nancy Sinatra

 

Where better for the wisdom of Nancy Sinatra to take root than in Las Vegas, site of this year’s HIMSS conference. There the evolution of advanced visualization was in plain and startling view.

A couple decades ago, advanced visualization was a complement to picture archiving and communication systems (PACS); software running on workstations and thin-client networks that did what PACS could not; a vehicle for delivering eye candy to radiologists willing to push back the frontier of medical visualization one new application at a time.

Back then, those workstations and thin-client networks looked like luxuries. They met the needs of only the elite of medical imaging. Their visualizations skirted the periphery of medicine — beautiful, but limited in their utility. It seemed all but inevitable, at least to me, that they would eventually become radiology’s equivalent of an ornate buggy whip, made obsolete inevitably by automobiles, one that despite its beauty was fated to go belly up. But it hasn’t. And it won’t. At least not any time soon.

Advanced visualization has reinvented itself. It survives as PACS fades, flourishing as the new sidekick to the successor of PACS, enterprise imaging.

The company once known as Vital Images, acquired several years ago by Toshiba and reborn as Vital, was busy at HIMSS 2016 carving out a new role for itself. It expanded on its visualization platform to offer interoperability spanning information systems across the enterprise. At the conference, Vital launched what the company described as a “personalized HIE/EMR viewing platform.”

Recognizing the inordinate — and growing — power of the C suite, Vital presented its new enterprise interoperability platform as “the CIO’s best friend.” Defined largely by what it does for healthcare, this platform was promoted as the means to better outcomes in accountable care, accomplishing this goal by providing common ground for electronic medical records, health information exchanges, VNAs and PACS.

It is, according to the company, a “personalized viewing platform,” a kind of “missing link.” Its toolkit, called “Vital Box,” is designed, says the company, for chief information officers and information technology vendors to integrate processes associated with electronic medical records and various multimedia sources, including VNAs and PACS.  As part of its mission, this platform supports a next generation “universal viewer” that provides access to traditional medical images contained in PACS, as well as other content, such as the multimedia files from disciplines outside radiology.

Also wedging itself at HIMSS 2016 into the gap between images and electronic medical records was TeraRecon, which not long ago was a pure play, thin-client provider of advanced visualization, offering renderings that stunningly eclipsed any that PACS could do. This was its special niche. But at HIMSS, TeraRecon introduced image sharing solutions that “support multiple workflow and user management scenarios.” Amid the TeraRecon portfolio was an enterprise viewer that could be configured to provide simple views as well as complex post-processed ones.

A major goal, according to the company, is to expedite the exchange of images among facilities, eliminating the need to send CDs bearing medical images. This image sharing includes options for exporting images to PACS, as well as the ability to distribute them across the enterprise, leveraging standards that go beyond DICOM, ones that cover cross-enterprise data exchanges. It includes the means for integrating these images with hospital enterprise user management systems so as to ensure, according to the company, easy and secure image exchange with specialists throughout an institution.

TeraRecon’s transformation has been in the works for a while. At HIMSS four years ago, the company highlighted efforts to image-enable the EMR using a scalable thin-client solution for processing and distributing images. Among its features was a zero-footprint, multimodality, browser-based enterprise viewer offering advanced image processing for radiological exams. At the core of these options then — and now — is interoperability, the ability to seamlessly integrate with EMR, the VNA, PACS and other healthcare information systems.

The transformation of these two companies is a sign of change in the world of medical imaging. It is certainly not the only such sign, but it is one that bears close attention, reflective of the new reality of value-based medicine and its demand that imaging play an increased role in both outcomes and fiscal responsibility.

In short, the comfortable surroundings sculpted by DICOM are giving way to the complex and multifaceted landscape of the image-enabled enterprise. It’s been a long time coming, but it’s picking up speed … and fast.

Radiology has two choices: adapt or be prepared, as Nancy sang, “to be walked all over.”

 

Editor’s note: This is the second blog in a series of four by industry consultant Greg Freiherr on MR Balances Speed and Clinical Reach. To read MR is About to Get Faster, Cheaper and More Valuable: It's About Time, click here.

Related Content

The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
The Galan 3T and Orian 1.5T magnetic resonance imaging (MRI) platforms, both with Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) and Compressed SPEEDER, will be featured at RSNA 2020.

Vantage Galan 3T

News | RSNA | October 02, 2020
October 2, 2020 — 
These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation.

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation. Higher signal intensity can be seen in the central white matter, particularly for the 31-week gestation infant. The bottom panels display the corresponding slices with objectively segmented DWMA in yellow. The 27-week infant (left) was diagnosed with mild DWMA, the 26-week infant (center) was diagnosed with moderate DWMA, and the 31-week infant had severe DWMA. Image courtesy of Cincinnati Children's and Nature Scientific Reports

News | Magnetic Resonance Imaging (MRI) | October 01, 2020
October 1, 2020 — As many as 70% of very premature infants (born earlier than 32 weeks gestation) show signs of white